Antibodies under a microscope

Database

Filter by:

Antibody Category
Suppliers
Applications
Antibody Types
Host Species
Species Reactivity

You are searching for:

  • Category A

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

  • Category B

    • Original source/host: Animal (historic hybridoma) OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    • Recombinantly reformatted hybridomas are included as they align with the May 2020 EURL ECVAM recommendation, which permits continued use of existing, sequenced, and well-characterised hybridomas to produce recombinant monoclonal antibodies in vitro, as animals are no longer directly involved
    • Naïve, non-immunised animal B cell-derived in vitro antibody display libraries align with the May 2020 EURL ECVAM recommendation to no longer authorise the development and production of antibodies through animal immunisation
    Search

  • Category C

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search

  • Category D

    • Original source/host: Animal OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search

  • Category E

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

  • Category F

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with animal-derived biomaterials used in production or final formulation
    Search

  • Category G

    • Original source/host: Unknown
    • Discovery method: Unknown
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

2731-2740 of 4090 results

Catalogue Number:

PX-TA1764

Category:

G

Proteo Genix logo

Fidasimtamab Biosimilar – Anti-HER2 & PD1 mAb – Research Grade

Target: HER2 & PD1
Target Alias Name: Fidasimtamab/BH-2950/ BH2950/ IBI 315/ IBI-315/ IBI315/HER2 & PD1/anti-HER2 & PD1
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1208

Category:

G

Proteo Genix logo

Figitumumab Biosimilar – Anti-IGF1R/ CD221 mAb – Research Grade

Target: IGF1R/ CD221
Target Alias Name: Figitumumab/CP-751871/IGF1R/ CD221/anti-IGF1R/ CD221
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG2-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1668

Category:

G

Proteo Genix logo

Finotonlimab Biosimilar – Anti-PDCD1 mAb – Research Grade

Target: PDCD1
Target Alias Name: Finotonlimab/FINOTONLIMAB/SCT-I10A/PDCD1/anti-PDCD1
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG4/Kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1948

Category:

G

Proteo Genix logo

Firastotug Biosimilar – Anti-CD152 mAb – Research Grade

Target: CD152
Target Alias Name: anti-CD152/ Cytotoxic T-lymphocyte protein 4/ CTLA-4/ CTLA4/ Cytotoxic T-lymphocyte-associated antigen 4
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1361

Category:

G

Proteo Genix logo

Firivumab Biosimilar – Anti-hemagglutinin HA mAb – Research Grade

Target: hemagglutinin HA
Target Alias Name: Firivumab/CT-P22/hemagglutinin HA/anti-hemagglutinin HA
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1841

Category:

G

Proteo Genix logo

Fiztasovimab Biosimilar – Anti-HHV gB AD-1 mAb – Research Grade

Target: HHV gB AD-1
Target Alias Name: Fiztasovimab//HHV gB AD-1/anti-HHV gB AD-1
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1 Lambda
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1280

Category:

G

Proteo Genix logo

Flanvotumab Biosimilar – Anti-TYRP1 mAb – Research Grade

Target: TYRP1
Target Alias Name: Flanvotumab/20D7S/IMC-20D7S/TYRP1/anti-TYRP1
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1336

Category:

G

Proteo Genix logo

Fletikumab Biosimilar – Anti-IL20 mAb – Research Grade

Target: IL20
Target Alias Name: Fletikumab/15D2/NN-8226/NNC-0109-0012/IL20 /anti-IL20
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG4-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1456

Category:

G

Proteo Genix logo

Flotetuzumab Biosimilar – Anti-CD3E/ IL3RA/ CD123 mAb – Research Grade

Target: CD3E/ IL3RA/ CD123
Target Alias Name: Flotetuzumab/MGD-006/MGD006/RES234/S80880/CD3E/ IL3RA/ CD123/anti-CD3E/ IL3RA/ CD123
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: VH-VL-VH'-VL'
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1043

Category:

G

Proteo Genix logo

Fontolizumab Biosimilar – Anti-IFNG mAb – Research Grade

Target: IFNG
Target Alias Name: Fontolizumab/HuZAF/IFNG/anti-IFNG
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-nd
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo